Human trials of lithium orotate for Alzheimer's to start spring 2026 at MGH/Brigham
Louis notes human trials of lithium orotate begin at MGH/Brigham in spring 2026, following Harvard findings that lithium deficiency may drive Alzheimer's even when amyloid plaques are present.



